Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 189-192

  Zee, Robert Y L ^a   Bubes, Vadim ^a   Shrivastava, Sanjay ^a,b   Ridker, Paul M ^a   Glynn, Robert J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

Candidate genes; Epistasis; Recurrent VTE

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHEMOKINE RECEPTOR CCR5; CHOLESTEROL ESTER TRANSFER PROTEIN; STROMELYSIN;

ADRB3 GENE; ADULT; APOA4 GENE; ARTICLE; CCR2 GENE; CETP GENE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FOLLOW UP; GC GENE; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL1A GENE; IL4R GENE; ITGA2 GENE; MAJOR CLINICAL STUDY; MALE; MMP3 GENE; PON1 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; TCF7 GENE; TNF GENE; VENOUS THROMBOEMBOLISM;

AGED; ALLELES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MONTE CARLO METHOD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 60649089836     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.01.011     Document Type: Article

References (19)

1. Hron G., Eichinger S., Weltermann A., et al. Family history for venous thromboembolism and the risk for recurrence. Am. J. Med. 119 (2006) 50-53
2. Cochery-Nouvellon E., Vitry F., Cornillet-Lefebvre P., Hezard N., Gillot L., and Nguyen P. Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study. Thromb. Haemost. 96 (2006) 24-28
3. Ho W.K., Hankey G.J., Quinlan D.J., and Eikelboom J.W. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch. Intern. Med. 166 (2006) 729-736
4. Jilma B., Kovar F.M., Hron G., et al. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism. Arch. Intern. Med. 166 (2006) 1655-1659
5. Marcucci R., Liotta A.A., Cellai A.P., et al. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am. J. Med. 115 (2003) 601-605
6. Oguzulgen I.K., Ekim N., Erkekol F.O., Altinok B., and Akar N. Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?. J. Thromb. Thrombolysis 19 (2005) 61-63
7. Fatini C., Gensini F., Sticchi E., et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur. J. Clin. Invest. 33 (2003) 642-647
8. Ridker P.M., Goldhaber S.Z., Danielson E., et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N. Engl. J. Med. 348 (2003) 1425-1434
9. Cheng S., Grow M.A., Pallaud C., et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res. 9 (1999) 936-949
10. Zee R.Y., Cook N.R., Cheng S., et al. Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum. Mol. Genet. 13 (2004) 389-396
11. Zee R.Y., Cook N.R., Cheng S., Erlich H.A., Lindpaintner K., and Ridker P.M. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis. Circulation 113 (2006) 2193-2200
12. Zee R.Y., Cook N.R., Cheng S., Erlich H.A., Lindpaintner K., and Ridker P.M. Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J. Thromb. Haemost. 4 (2006) 341-348
13. Kooperberg C., and Ruczinski I. Identifying interacting SNPs using Monte Carlo logic regression. Genet. Epidemiol. 28 (2005) 157-170
14. Green P.J. Reversible jump Markov Chain Monte Carlo computation and Bayesian Model determination. Biometrika 82 (1995) 711-732
15. Kooperberg C., Bis J.C., Marciante K.D., Heckbert S.R., Lumley T., and Psaty B.M. Logic regression for analysis of the association between genetic variation in the renin-angiotensin system and myocardial infarction or stroke. Am. J. Epidemiol. (2006)
16. Grubic N., Stegnar M., Peternel P., Kaider A., and Binder B.R. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Thromb. Res. 84 (1996) 431-443
17. Mansilha A., Araujo F., Severo M., Sampaio S.M., Toledo T., and Albuquerque R. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur. J. Vasc. Endovasc. Surg. 30 (2005) 545-549
18. Sanada H., Yatabe J., Midorikawa S., et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin. Chem. 52 (2006) 352-360
19. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57 (1995) 289-300